Published in Cell on December 21, 2012
Induction of pluripotency in mouse somatic cells with lineage specifiers. Cell (2013) 2.69
Epigenetic memory at embryonic enhancers identified in DNA methylation maps from adult mouse tissues. Nat Genet (2013) 2.41
Genome-wide characterization of the routes to pluripotency. Nature (2014) 2.34
Divergent reprogramming routes lead to alternative stem-cell states. Nature (2014) 2.31
Nonstochastic reprogramming from a privileged somatic cell state. Cell (2014) 2.13
The RNA-binding protein repertoire of embryonic stem cells. Nat Struct Mol Biol (2013) 2.12
Mechanisms and models of somatic cell reprogramming. Nat Rev Genet (2013) 2.09
Genome-wide chromatin interactions of the Nanog locus in pluripotency, differentiation, and reprogramming. Cell Stem Cell (2013) 1.91
Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature (2014) 1.81
Chromatin dynamics during cellular reprogramming. Nature (2013) 1.79
Epigenetics of reprogramming to induced pluripotency. Cell (2013) 1.73
A continuous molecular roadmap to iPSC reprogramming through progression analysis of single-cell mass cytometry. Cell Stem Cell (2015) 1.67
Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell (2013) 1.63
Lineage conversion induced by pluripotency factors involves transient passage through an iPSC stage. Nat Biotechnol (2015) 1.55
Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming. Cell Stem Cell (2015) 1.53
Genetic background drives transcriptional variation in human induced pluripotent stem cells. PLoS Genet (2014) 1.53
A blueprint for engineering cell fate: current technologies to reprogram cell identity. Cell Res (2013) 1.50
High-resolution analysis with novel cell-surface markers identifies routes to iPS cells. Nature (2013) 1.48
Local Genome Topology Can Exhibit an Incompletely Rewired 3D-Folding State during Somatic Cell Reprogramming. Cell Stem Cell (2016) 1.46
Gut microbial metabolites limit the frequency of autoimmune T cells and protect against type 1 diabetes. Nat Immunol (2017) 1.43
Model of fibrolamellar hepatocellular carcinomas reveals striking enrichment in cancer stem cells. Nat Commun (2015) 1.43
Generation and characterization of induced pluripotent stem cells from Aid-deficient mice. PLoS One (2014) 1.43
Müller glial cell reprogramming and retina regeneration. Nat Rev Neurosci (2014) 1.37
Direct activation of human and mouse Oct4 genes using engineered TALE and Cas9 transcription factors. Nucleic Acids Res (2014) 1.34
Proteomic and genomic approaches reveal critical functions of H3K9 methylation and heterochromatin protein-1γ in reprogramming to pluripotency. Nat Cell Biol (2013) 1.33
Systematic identification of barriers to human iPSC generation. Cell (2014) 1.33
Loss of transcriptional control over endogenous retroelements during reprogramming to pluripotency. Genome Res (2014) 1.30
Genome-wide functional analysis reveals factors needed at the transition steps of induced reprogramming. Cell Rep (2014) 1.23
INO80 facilitates pluripotency gene activation in embryonic stem cell self-renewal, reprogramming, and blastocyst development. Cell Stem Cell (2014) 1.22
Reprogramming to pluripotency using designer TALE transcription factors targeting enhancers. Stem Cell Reports (2013) 1.22
Molecular control of induced pluripotency. Cell Stem Cell (2014) 1.22
The THO complex regulates pluripotency gene mRNA export and controls embryonic stem cell self-renewal and somatic cell reprogramming. Cell Stem Cell (2013) 1.19
AID stabilizes stem-cell phenotype by removing epigenetic memory of pluripotency genes. Nature (2013) 1.18
An epigenomic roadmap to induced pluripotency reveals DNA methylation as a reprogramming modulator. Nat Commun (2014) 1.18
Platform for induction and maintenance of transgene-free hiPSCs resembling ground state pluripotent stem cells. Stem Cell Reports (2014) 1.18
A decade of transcription factor-mediated reprogramming to pluripotency. Nat Rev Mol Cell Biol (2016) 1.16
Maturation, not initiation, is the major roadblock during reprogramming toward pluripotency from human fibroblasts. Proc Natl Acad Sci U S A (2013) 1.14
The intertwined roles of transcription and repair proteins. Mol Cell (2013) 1.13
Hypoxia-inducible factors have distinct and stage-specific roles during reprogramming of human cells to pluripotency. Cell Stem Cell (2014) 1.13
Nanog is dispensable for the generation of induced pluripotent stem cells. Curr Biol (2014) 1.12
Defined three-dimensional microenvironments boost induction of pluripotency. Nat Mater (2016) 1.11
A predictive computational framework for direct reprogramming between human cell types. Nat Genet (2016) 1.10
Induction of diverse cardiac cell types by reprogramming fibroblasts with cardiac transcription factors. Development (2014) 1.10
Nanog-independent reprogramming to iPSCs with canonical factors. Stem Cell Reports (2014) 1.05
Reprogramming of cell fate: epigenetic memory and the erasure of memories past. EMBO J (2015) 1.05
Two miRNA clusters reveal alternative paths in late-stage reprogramming. Cell Stem Cell (2014) 1.04
Small molecules facilitate rapid and synchronous iPSC generation. Nat Methods (2014) 1.04
microRNA control of mouse and human pluripotent stem cell behavior. Annu Rev Cell Dev Biol (2013) 1.02
The p53-induced lincRNA-p21 derails somatic cell reprogramming by sustaining H3K9me3 and CpG methylation at pluripotency gene promoters. Cell Res (2014) 1.02
Analysis of DNA methylation reveals a partial reprogramming of the Müller glia genome during retina regeneration. Proc Natl Acad Sci U S A (2013) 1.02
H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes. Trends Genet (2015) 0.98
Do all roads lead to Oct4? the emerging concepts of induced pluripotency. Trends Cell Biol (2013) 0.98
Integrative Analyses of Human Reprogramming Reveal Dynamic Nature of Induced Pluripotency. Cell (2015) 0.97
The histone chaperone CAF-1 safeguards somatic cell identity. Nature (2015) 0.97
Combinatorial modulation of signaling pathways reveals cell-type-specific requirements for highly efficient and synchronous iPSC reprogramming. Stem Cell Reports (2014) 0.96
The chemistry of regulation of genes and other things. J Biol Chem (2014) 0.96
Early ERK1/2 activation promotes DRP1-dependent mitochondrial fission necessary for cell reprogramming. Nat Commun (2016) 0.96
Myc and SAGA rewire an alternative splicing network during early somatic cell reprogramming. Genes Dev (2015) 0.95
MicroRNA-based discovery of barriers to dedifferentiation of fibroblasts to pluripotent stem cells. Nat Struct Mol Biol (2013) 0.95
p63 attenuates epithelial to mesenchymal potential in an experimental prostate cell model. PLoS One (2013) 0.94
Cellular reprogramming of human peripheral blood cells. Genomics Proteomics Bioinformatics (2013) 0.94
A genome-wide RNAi screen identifies opposing functions of Snai1 and Snai2 on the Nanog dependency in reprogramming. Mol Cell (2014) 0.94
Molecular features of cellular reprogramming and development. Nat Rev Mol Cell Biol (2016) 0.93
Early reprogramming regulators identified by prospective isolation and mass cytometry. Nature (2015) 0.92
Metabolic Reprogramming of Stem Cell Epigenetics. Cell Stem Cell (2015) 0.91
Differential role of nonhomologous end joining factors in the generation, DNA damage response, and myeloid differentiation of human induced pluripotent stem cells. Proc Natl Acad Sci U S A (2014) 0.90
Evaluating cell reprogramming, differentiation and conversion technologies in neuroscience. Nat Rev Neurosci (2016) 0.90
A Comparative View on Human Somatic Cell Sources for iPSC Generation. Stem Cells Int (2014) 0.90
Energy metabolism in the acquisition and maintenance of stemness. Semin Cell Dev Biol (2016) 0.90
Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion. Nat Commun (2015) 0.90
The polycomb protein Ezh2 impacts on induced pluripotent stem cell generation. Stem Cells Dev (2014) 0.89
X chromosome reactivation dynamics reveal stages of reprogramming to pluripotency. Cell (2014) 0.89
Single-cell transcriptome analysis reveals dynamic changes in lncRNA expression during reprogramming. Cell Stem Cell (2015) 0.88
Temporal perturbation of the Wnt signaling pathway in the control of cell reprogramming is modulated by TCF1. Stem Cell Reports (2014) 0.88
Counteracting activities of OCT4 and KLF4 during reprogramming to pluripotency. Stem Cell Reports (2014) 0.87
Spatiotemporal variation of mammalian protein complex stoichiometries. Genome Biol (2016) 0.87
Establishment of leukemia inhibitory factor (LIF)-independent iPS cells with potentiated Oct4. Stem Cell Res (2015) 0.87
Mathematical approaches to modeling development and reprogramming. Proc Natl Acad Sci U S A (2014) 0.87
MicroRNAs and Cardiac Regeneration. Circ Res (2015) 0.86
The extended pluripotency protein interactome and its links to reprogramming. Curr Opin Genet Dev (2014) 0.86
Epigenetic state network approach for describing cell phenotypic transitions. Interface Focus (2014) 0.86
Collaborative rewiring of the pluripotency network by chromatin and signalling modulating pathways. Nat Commun (2015) 0.86
Stem cells: Surf the waves of reprogramming. Nature (2013) 0.85
The use of small molecules in somatic-cell reprogramming. Trends Cell Biol (2013) 0.85
Deregulation of epigenetic mechanisms by the hepatitis B virus X protein in hepatocarcinogenesis. Viruses (2013) 0.85
ERRs Mediate a Metabolic Switch Required for Somatic Cell Reprogramming to Pluripotency. Cell Stem Cell (2015) 0.85
The dyskerin ribonucleoprotein complex as an OCT4/SOX2 coactivator in embryonic stem cells. Elife (2014) 0.85
Understanding the roadmaps to induced pluripotency. Cell Death Dis (2014) 0.85
Translation of Human-Induced Pluripotent Stem Cells: From Clinical Trial in a Dish to Precision Medicine. J Am Coll Cardiol (2016) 0.85
Induction of pluripotency by defined factors. Proc Jpn Acad Ser B Phys Biol Sci (2014) 0.84
CD44 is a negative cell surface marker for pluripotent stem cell identification during human fibroblast reprogramming. PLoS One (2014) 0.84
Manipulation of KLF4 expression generates iPSCs paused at successive stages of reprogramming. Stem Cell Reports (2014) 0.84
Epigenetics of cellular reprogramming. Curr Opin Genet Dev (2013) 0.84
An animated landscape representation of CD4+ T-cell differentiation, variability, and plasticity: insights into the behavior of populations versus cells. Eur J Immunol (2014) 0.83
Epigenetic predisposition to reprogramming fates in somatic cells. EMBO Rep (2015) 0.83
Toward directed reprogramming through exogenous factors. Curr Opin Genet Dev (2013) 0.83
Netrin-1 regulates somatic cell reprogramming and pluripotency maintenance. Nat Commun (2015) 0.83
Mechanisms for enhancing cellular reprogramming. Curr Opin Genet Dev (2014) 0.82
The Importance of Ubiquitination and Deubiquitination in Cellular Reprogramming. Stem Cells Int (2016) 0.82
Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell (2006) 120.51
Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell (2007) 101.42
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Dissecting direct reprogramming through integrative genomic analysis. Nature (2008) 16.47
Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet (2012) 15.21
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell (2008) 12.45
Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells. Cell Stem Cell (2008) 12.29
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
A mesenchymal-to-epithelial transition initiates and is required for the nuclear reprogramming of mouse fibroblasts. Cell Stem Cell (2010) 7.94
Functional genomics reveals a BMP-driven mesenchymal-to-epithelial transition in the initiation of somatic cell reprogramming. Cell Stem Cell (2010) 7.51
Role of the murine reprogramming factors in the induction of pluripotency. Cell (2009) 7.46
Single-cell expression analyses during cellular reprogramming reveal an early stochastic and a late hierarchic phase. Cell (2012) 7.17
Elite and stochastic models for induced pluripotent stem cell generation. Nature (2009) 5.06
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Dynamic single-cell imaging of direct reprogramming reveals an early specifying event. Nat Biotechnol (2010) 3.98
Reprogramming factor expression initiates widespread targeted chromatin remodeling. Cell Stem Cell (2011) 3.16
Chromatin connections to pluripotency and cellular reprogramming. Cell (2011) 3.07
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat Methods (2009) 2.65
Regulation of pluripotency and cellular reprogramming by the ubiquitin-proteasome system. Cell Stem Cell (2012) 2.35
Highly coordinated proteome dynamics during reprogramming of somatic cells to pluripotency. Cell Rep (2012) 1.84
BMPs functionally replace Klf4 and support efficient reprogramming of mouse fibroblasts by Oct4 alone. Cell Res (2010) 1.51
Fast network component analysis (FastNCA) for gene regulatory network reconstruction from microarray data. Bioinformatics (2008) 1.23
From microRNAs to targets: pathway discovery in cell fate transitions. Curr Opin Genet Dev (2011) 1.15
Discovery of nonsteroidal anti-inflammatory drug and anticancer drug enhancing reprogramming and induced pluripotent stem cell generation. Stem Cells (2011) 1.08
Normal embryonic and germ cell development in mice lacking alpha 1,3-fucosyltransferase IX (Fut9) which show disappearance of stage-specific embryonic antigen 1. Mol Cell Biol (2004) 1.08
Pivots of pluripotency: the roles of non-coding RNA in regulating embryonic and induced pluripotent stem cells. Biochim Biophys Acta (2012) 1.00
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature (2007) 28.24
Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution. Cell Stem Cell (2007) 21.58
Disease-specific induced pluripotent stem cells. Cell (2008) 16.95
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
Integrative genomic analyses identify MITF as a lineage survival oncogene amplified in malignant melanoma. Nature (2005) 15.28
Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell (2010) 15.20
Induced pluripotent stem cells generated without viral integration. Science (2008) 13.38
Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse. Cell Stem Cell (2008) 12.45
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1. Nature (2009) 11.46
A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations. Cell (2010) 11.20
Circulating breast tumor cells exhibit dynamic changes in epithelial and mesenchymal composition. Science (2013) 10.87
Pseudogene-derived small interfering RNAs regulate gene expression in mouse oocytes. Nature (2008) 10.71
Prognostic relevance of integrated genetic profiling in acute myeloid leukemia. N Engl J Med (2012) 10.20
A mechanism of cyclin D1 action encoded in the patterns of gene expression in human cancer. Cell (2003) 9.81
Global mapping of H3K4me3 and H3K27me3 reveals specificity and plasticity in lineage fate determination of differentiating CD4+ T cells. Immunity (2009) 9.73
Cell type of origin influences the molecular and functional properties of mouse induced pluripotent stem cells. Nat Biotechnol (2010) 9.24
Characterization of Dicer-deficient murine embryonic stem cells. Proc Natl Acad Sci U S A (2005) 8.35
IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 7.95
Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming. Nat Biotechnol (2009) 7.59
Guidelines and techniques for the generation of induced pluripotent stem cells. Cell Stem Cell (2008) 7.57
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation. Cancer Cell (2011) 7.37
Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells. Nature (2010) 7.05
Immortalization eliminates a roadblock during cellular reprogramming into iPS cells. Nature (2009) 6.85
DNA methylation signatures identify biologically distinct subtypes in acute myeloid leukemia. Cancer Cell (2010) 6.72
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells. Genesis (2006) 6.64
Synthetic lethal interaction between oncogenic KRAS dependency and STK33 suppression in human cancer cells. Cell (2009) 6.55
A high-efficiency system for the generation and study of human induced pluripotent stem cells. Cell Stem Cell (2008) 5.99
Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res (2006) 5.99
A novel miRNA processing pathway independent of Dicer requires Argonaute2 catalytic activity. Science (2010) 5.84
Induced pluripotent stem cell generation using a single lentiviral stem cell cassette. Stem Cells (2009) 5.69
Oct4 expression is not required for mouse somatic stem cell self-renewal. Cell Stem Cell (2007) 5.29
Distinct roles of Akt1 and Akt2 in regulating cell migration and epithelial-mesenchymal transition. J Cell Biol (2005) 5.00
Induced pluripotency: history, mechanisms, and applications. Genes Dev (2010) 4.89
Incomplete DNA methylation underlies a transcriptional memory of somatic cells in human iPS cells. Nat Cell Biol (2011) 4.77
The melanocyte differentiation program predisposes to metastasis after neoplastic transformation. Nat Genet (2005) 4.70
Reprogramming of neural progenitor cells into induced pluripotent stem cells in the absence of exogenous Sox2 expression. Stem Cells (2008) 4.67
Correction of a genetic defect by nuclear transplantation and combined cell and gene therapy. Cell (2002) 4.56
Basophils produce IL-4 and accumulate in tissues after infection with a Th2-inducing parasite. J Exp Med (2004) 4.45
Analysis of histone 2B-GFP retention reveals slowly cycling hematopoietic stem cells. Nat Biotechnol (2008) 4.41
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res (2012) 4.34
How are T(H)2-type immune responses initiated and amplified? Nat Rev Immunol (2010) 4.34
Reprogramming of pancreatic beta cells into induced pluripotent stem cells. Curr Biol (2008) 4.34
Sox2(+) adult stem and progenitor cells are important for tissue regeneration and survival of mice. Cell Stem Cell (2011) 4.29
Differentiation stage determines potential of hematopoietic cells for reprogramming into induced pluripotent stem cells. Nat Genet (2009) 4.28
IDH1(R132H) mutation increases murine haematopoietic progenitors and alters epigenetics. Nature (2012) 4.04
MDS and secondary AML display unique patterns and abundance of aberrant DNA methylation. Blood (2009) 4.00
Distinct roles for JNK1 and JNK2 in regulating JNK activity and c-Jun-dependent cell proliferation. Mol Cell (2004) 3.94
Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat Immunol (2011) 3.91
Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. Cancer Res (2002) 3.90
Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell (2002) 3.72
BCL6 enables Ph+ acute lymphoblastic leukaemia cells to survive BCR-ABL1 kinase inhibition. Nature (2011) 3.63
Hematopoietic stem cells expressing the myeloid lysozyme gene retain long-term, multilineage repopulation potential. Immunity (2003) 3.59
methylKit: a comprehensive R package for the analysis of genome-wide DNA methylation profiles. Genome Biol (2012) 3.44
RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature (2012) 3.40
Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest (2002) 3.36
Platelets regulate lymphatic vascular development through CLEC-2-SLP-76 signaling. Blood (2010) 3.35
Recurrent somatic TET2 mutations in normal elderly individuals with clonal hematopoiesis. Nat Genet (2012) 3.33
Specific peptide interference reveals BCL6 transcriptional and oncogenic mechanisms in B-cell lymphoma cells. Nat Med (2004) 3.10
Differential modeling of fragile X syndrome by human embryonic stem cells and induced pluripotent stem cells. Cell Stem Cell (2010) 3.08
MicroRNA miR-210 modulates cellular response to hypoxia through the MYC antagonist MNT. Cell Cycle (2009) 3.07
Chromatin connections to pluripotency and cellular reprogramming. Cell (2011) 3.07
A small-molecule inhibitor of BCL6 kills DLBCL cells in vitro and in vivo. Cancer Cell (2010) 3.05
Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci U S A (2004) 2.98
The sox family of transcription factors: versatile regulators of stem and progenitor cell fate. Cell Stem Cell (2013) 2.97
Base-pair resolution DNA methylation sequencing reveals profoundly divergent epigenetic landscapes in acute myeloid leukemia. PLoS Genet (2012) 2.94
Bcl-6 mediates the germinal center B cell phenotype and lymphomagenesis through transcriptional repression of the DNA-damage sensor ATR. Nat Immunol (2007) 2.90
Tgfbeta signal inhibition cooperates in the induction of iPSCs and replaces Sox2 and cMyc. Curr Biol (2009) 2.89
A peptomimetic inhibitor of BCL6 with potent antilymphoma effects in vitro and in vivo. Blood (2008) 2.85
IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A (2009) 2.83
The Eph-receptor A7 is a soluble tumor suppressor for follicular lymphoma. Cell (2011) 2.83
Critical role of CDK2 for melanoma growth linked to its melanocyte-specific transcriptional regulation by MITF. Cancer Cell (2004) 2.80
Androgen receptor signaling in circulating tumor cells as a marker of hormonally responsive prostate cancer. Cancer Discov (2012) 2.76
A method for genetic modification of human embryonic stem cells using electroporation. Nat Protoc (2007) 2.76
Harnessing the potential of induced pluripotent stem cells for regenerative medicine. Nat Cell Biol (2011) 2.74
Outcome of deferred initial therapy in mantle-cell lymphoma. J Clin Oncol (2009) 2.70
A murine ESC-like state facilitates transgenesis and homologous recombination in human pluripotent stem cells. Cell Stem Cell (2010) 2.65
A reprogrammable mouse strain from gene-targeted embryonic stem cells. Nat Methods (2009) 2.65
Reprogramming of committed T cell progenitors to macrophages and dendritic cells by C/EBP alpha and PU.1 transcription factors. Immunity (2006) 2.58
Heterogeneity of embryonic and adult stem cells. Cell Stem Cell (2008) 2.57
Independent roles for IL-2 and GATA-3 in stimulating naive CD4+ T cells to generate a Th2-inducing cytokine environment. J Exp Med (2005) 2.57
Mutant DNMT3A: a marker of poor prognosis in acute myeloid leukemia. Blood (2012) 2.55
Genome-wide analyses of transcription factor GATA3-mediated gene regulation in distinct T cell types. Immunity (2011) 2.53
Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell (2013) 2.51
CG dinucleotide clustering is a species-specific property of the genome. Nucleic Acids Res (2007) 2.48
GATA3 controls Foxp3⁺ regulatory T cell fate during inflammation in mice. J Clin Invest (2011) 2.43
Affinity-based proteomics reveal cancer-specific networks coordinated by Hsp90. Nat Chem Biol (2011) 2.42